Abstract P2-08-03: Survival analysis of the prospective randomized Cher-Lob study: Correlation with tumor infiltrating lymphocytes
Dieci, MV, Bisagni, G, Cagossi, K, Generali, DG, Sarti, S, Piacentini, F, Conte, P, Guarneri, V
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract P4-21-11: T-DM1 in HER2 positive advanced breast cancer patients: Real world practice from a multicenter observational study
Fabi, A, De Laurentiis, M, Caruso, M, Valle, E, Moscetti, L, Santini, D, Cannita, K, Carbognin, L, Ciccarese, M, Rossello, R, Arpino, G, Leonardi, V, Montemurro, F, La Verde, N, Generali, DG, Zambelli, A, Scandurra, G, Russillo, M, Paris, I, D'Ottavio, AM, Filippelli, G, Giampaglia, M, Stani, S, Fabbri, A, Alesini, D, Giannarelli, D, Cognetti, F
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
P4-16-03: Proof of the Anti-Tumour Effect of Zoledronic Acid (ZA) in Naive Bone-Only Metastatic and Locally Advanced Breast Cancer: Results from the Biological Window Therapy
Foroni, C, Andreis, D, Maldotti, M, Cappelletti, MR, Generali, DG
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article